MS. ANJALI BAL – Internal Medicine Physician, NPI 1164818910
Internal Medicine Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
177 RHEUMATOLOGY in VA
Provider Addresses for MS. ANJALI BAL
PO BOX 9007
CHARLOTTESVILLE, VA 229069007
Phone: (434) 295-1000
Fax: (434) 972-4266
Type: Mailing
1215 LEE ST
CHARLOTTESVILLE, VA 22908
Phone: (434) 924-1931
Fax: (434) 243-5770
Type: Location
2360 MARYLAND RD
WILLOW GROVE, PA 190901709
Phone: (434) 295-1000
Fax: (434) 972-4266
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 180 Open Payments records for all available years, with a total value of $3,500.
Total Amount is formed as General ($3,500) + Research ($0) + Ownership ($0) = $3,500.
Last reported payment date: 2024-12-20 • Largest payer in this snapshot: ABBVIE INC. ($504).
Total Amount
$3,500
General + Research + Ownership
Payments
180
Total payment records
General Amount
$3,500
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-20
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| ABBVIE INC. | $504 |
| Amgen Inc. | $484 |
| PFIZER INC. | $381 |
| Janssen Biotech, Inc. | $259 |
| AstraZeneca Pharmaceuticals LP | $135 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2021-06-24
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking 2 Medicare enrollment records; no due dates published yet.
Enrollment records
2
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20180712001653 | I | Internal Medicine | VA | TBD |
| I20210624001067 | I | Rheumatology | PA | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 17,200 | 31 | $0 |
| J3262 | Injection, tocilizumab, 1 mg | 14,800 | 16 | $0 |
| J0897 | Injection, denosumab, 1 mg | 10,380 | 149 | $0 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 8,820 | 29 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 6,600 | 26 | $0 |
Insurance plans in this area (ZIP 22906)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| R H E U M A T O L O G Y | PA | |
| R H E U M A T O L O G Y | PA | |
| - | PA | |
| Rheumatology, Internal Medicine | PA | |
| - | PA | |
| Rheumatology, Internal Medicine | PA | |
| R H E U M A T O L O G Y | PA | |
| R H E U M A T O L O G Y | PA | |
| R H E U M A T O L O G Y | PA | |
| R H E U M A T O L O G Y | NJ |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.